GovWire

Research: Use of UK plasma for the manufacture of albumins and vCJD risk

Commission On Human Medicines

August 15
16:22 2023

Details

The vCJD safety of using UK-sourced plasma for the manufacture of albumin medicinal products was considered. Based on current epidemiology, manufacturing process capability, expert advice and information collected for previous reviews, it was concluded that UK-sourced plasma can be used for the manufacture of albumin medicinal products, in addition to the already approved use for the manufacture of immunoglobulins.

Published 15 August 2023

Recent Comments

Follow Us on Twitter

Share This


Enjoyed this? Why not share it with others if you've found it useful by using one of the tools below: